Neurofeedback Intervention for Preclinical Alzheimer's Disease

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

August 1, 2019

Study Completion Date

December 31, 2019

Conditions
Alzheimer DiseaseSubjective Cognitive DeclineNeurofeedbackElectroencephalogram
Interventions
BEHAVIORAL

Electroencephalogram-based neurofeedback

In this project, SCD participants will receive electroencephalogram-based neurofeedback therapy, once a day, for 5 days. Then, the investigators will compare their memory changes between baseline and post-therapy visits.

Trial Locations (1)

100053

Department of Neurolgy, Xuanwu Hospital of Capital Medical University, Beijing

All Listed Sponsors
collaborator

Beijing Institute of Technology

OTHER

lead

XuanwuH 2

OTHER

NCT04300933 - Neurofeedback Intervention for Preclinical Alzheimer's Disease | Biotech Hunter | Biotech Hunter